Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cognitive decline following acute viral infections: literature review and projections for post-COVID-19
Rodolfo Furlan Damiano, Bruno Fukelmann Guedes, Cristiana Castanho de Almeida Rocca, et al.
European Archives of Psychiatry and Clinical Neuroscience (2021) Vol. 272, Iss. 1, pp. 139-154
Open Access | Times Cited: 80

Showing 1-25 of 80 citing articles:

Signalling cognition: the gut microbiota and hypothalamic-pituitary-adrenal axis
Jody Rusch, Brian T. Layden, Lara R. Dugas
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 97
Risk factors and abnormal cerebrospinal fluid associate with cognitive symptoms after mild COVID‐19
Alexandra C. Apple, Alexis P. Oddi, Michael J. Peluso, et al.
Annals of Clinical and Translational Neurology (2022) Vol. 9, Iss. 2, pp. 221-226
Open Access | Times Cited: 75
Repetitive injury induces phenotypes associated with Alzheimer’s disease by reactivating HSV-1 in a human brain tissue model
Dana M. Cairns, Brooke M. Smiley, Jordan A. Smiley, et al.
Science Signaling (2025) Vol. 18, Iss. 868
Closed Access | Times Cited: 1
Potential Involvement of Varicella Zoster Virus in Alzheimer’s Disease via Reactivation of Quiescent Herpes Simplex Virus Type 1
Dana M. Cairns, Ruth F. Itzhaki, David L. Kaplan
Journal of Alzheimer s Disease (2022) Vol. 88, Iss. 3, pp. 1189-1200
Closed Access | Times Cited: 65
Arketamine for cognitive impairment in psychiatric disorders
Kenji Hashimoto
European Archives of Psychiatry and Clinical Neuroscience (2023) Vol. 273, Iss. 7, pp. 1513-1525
Open Access | Times Cited: 31
Neurological manifestations of SARS-CoV-2: complexity, mechanism and associated disorders
Kritika Tyagi, Prachi Rai, Anuj Gautam, et al.
European journal of medical research (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 26
Subjective and Objective Cognitive Impairments in Non-Hospitalized Persons 9 Months after SARS-CoV-2 Infection
Inge Kirchberger, Daniela Peilstöcker, Tobias Dominik Warm, et al.
Viruses (2023) Vol. 15, Iss. 1, pp. 256-256
Open Access | Times Cited: 25
Cognitive impairment in long-COVID and its association with persistent dysregulation in inflammatory markers
Rodolfo Furlan Damiano, Cristiana Castanho de Almeida Rocca, Antônio de Pádua Serafim, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 24
Associations between olfactory dysfunction and cognition: a scoping review
Patricia T. Jacobson, Brandon J. Vilarello, Jeremy P. Tervo, et al.
Journal of Neurology (2024) Vol. 271, Iss. 3, pp. 1170-1203
Closed Access | Times Cited: 7
Antigen‐specific and cross‐reactive T cells in protection and disease
Ning Jiang, Michael Malone, Shahab Chizari
Immunological Reviews (2023) Vol. 316, Iss. 1, pp. 120-135
Closed Access | Times Cited: 16
Biochemical changes in subregions of the cingulate gyrus in patients with post-COVID syndrome
А. Г. Труфанов, I. A. Voznyuk, Anna Kutkova, et al.
The European Physical Journal Special Topics (2025)
Closed Access
Headmen, shamans, and mothers: Natural and sexual selection for computational services
Edward H. Hagen, Zachary H. Garfield, Aaron D. Lightner
Evolution and Human Behavior (2025) Vol. 46, Iss. 1, pp. 106651-106651
Closed Access
ADAR Editing in Viruses: An Evolutionary Force to Reckon with
Helen Piontkivska, Benjamin Wales-McGrath, Michael M. Miyamoto, et al.
Genome Biology and Evolution (2021) Vol. 13, Iss. 11
Open Access | Times Cited: 37
Six-month follow-up of multidomain cognitive impairment in non-hospitalized individuals with post-COVID-19 syndrome
Ann‐Katrin Schild, Daniel Scharfenberg, Anton Regorius, et al.
European Archives of Psychiatry and Clinical Neuroscience (2024) Vol. 274, Iss. 8, pp. 1945-1957
Open Access | Times Cited: 4
Post-COVID-19 Neuropathology and Perspectives of Protective Roles of Estrogens
Rodrigo Portes Ureshino, Roberta Sessa Stilhano, Carla M. Prado, et al.
COVID (2025) Vol. 5, Iss. 1, pp. 9-9
Open Access
T cell exhaustion is associated with cognitive status and amyloid accumulation in Alzheimer’s disease
Jason M. Grayson, Samantha M. Short, Chan-Ju Lee, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 12
Microglia at the scene of the crime: what their transcriptomics reveal about brain health
Artem Arutyunov, Robyn S. Klein
Current Opinion in Neurology (2023) Vol. 36, Iss. 3, pp. 207-213
Closed Access | Times Cited: 10
Association between COVID-19 infection and new-onset dementia in older adults: a systematic review and meta-analysis
Dan Shan, Congxiyu Wang, Trevor J. Crawford, et al.
BMC Geriatrics (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
The role of antiviral CD8+ T cells in cognitive impairment
Katie L. Reagin, Kristen E. Funk
Current Opinion in Neurobiology (2022) Vol. 76, pp. 102603-102603
Open Access | Times Cited: 18
Monocytosis in the acute phase of SARS-CoV-2 infection predicts the presence of anosognosia for cognitive deficits in the chronic phase
Anthony Nuber‐Champier, Philippe Voruz, Isabele Jacot de Alcântara, et al.
Brain Behavior & Immunity - Health (2022) Vol. 26, pp. 100511-100511
Open Access | Times Cited: 15
Targeting the microbiota-mitochondria crosstalk in neurodegeneration with senotherapeutics
Jan Homolak
Advances in protein chemistry and structural biology (2023), pp. 339-383
Closed Access | Times Cited: 8
NeuroCOVID-19: a critical review
Bruno Fukelmann Guedes
Arquivos de Neuro-Psiquiatria (2022) Vol. 80, Iss. 5 suppl 1, pp. 281-289
Open Access | Times Cited: 12
Astrocytes as Drivers and Disruptors of Behavior: New Advances in Basic Mechanisms and Therapeutic Targeting
Daniel Barnett, Kirsten Bohmbach, Valentin Grelot, et al.
Journal of Neuroscience (2023) Vol. 43, Iss. 45, pp. 7463-7471
Open Access | Times Cited: 7
A network perspective on neuropsychiatric and cognitive symptoms of the post-COVID syndrome
Daniel Scharfenberg, Ann‐Katrin Schild, Clemens Warnke, et al.
Europe’s Journal of Psychology (2022) Vol. 18, Iss. 4, pp. 350-356
Open Access | Times Cited: 11
COVID-19 and Alzheimer’s Disease: What Is the Connection?
Ruth F. Itzhaki
Journal of Alzheimer s Disease (2022) Vol. 91, Iss. 4, pp. 1273-1276
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top